Skip to main content

Mahoney Michael F's Form 4 filing

Boston Scientific Corp (BSX) · filed Oct 10, 2023

Accession no.
0001225208-23-009460
Filed
Oct 10, 2023
Trade date
Oct 9, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.90M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mahoney Michael FCIK 0001533022Director, Officer (Chairman, President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 9, 2023Common StockMOption exerciseAcquired+57,680$13.08+$754,454.41,556,602Direct
Oct 9, 2023Common StockMOption exerciseAcquired+55,675$16.31+$908,059.251,612,277Direct
Oct 9, 2023Common StockSSaleDisposed−113,355$52.09F2−$5,904,661.951,498,922Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 9, 2023Common StockMOption exerciseDisposed−55,675$0.00$0222,701Direct
Oct 9, 2023Common StockMOption exerciseDisposed−57,680$0.00$057,681Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.83 to $52.41, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)